The New Quality Productive Forces Seminar, co-hosted by the Macroeconomic Magazine of the National Development and Reform Commission and the Editorial Committee of the China Private Equity Fund Yearbook, was successfully held. During the seminar, the China Private Equity Fund Yearbook (2024) was officially released.

To provide a more comprehensive overview of the industry's development, the Editorial Committee of the China Private Equity Fund Yearbook conducted a comprehensive evaluation of over 20,000 private equity fund managers in China across more than 20 dimensions, leveraging its database and years of on-site due diligence. Taking into account the differences among securities, equity, and venture capital private equity fund managers, the Yearbook included the top 1% of the industry, representing more than 200 outstanding private equity fund managers. Among them, Efung Capital was recognized as an Outstanding Private Equity Manager (Venture Capital) in the China Private Equity Fund Yearbook (2024), thanks to its exceptional investment performance and deep industry insights.

Looking ahead, Efung Capital will continue to深耕 the biopharmaceutical and hard technology sectors, leveraging its professional investment team and extensive industry resources. Through capital empowerment and resource connection, Efung Capital will facilitate the transformation and commercialization of technological achievements, partnering with portfolio companies to navigate market cycles and jointly drive the high-quality development of China's healthcare and technological innovation sectors.